Recherche
-
Comment la modélisation peut-elle aider au développement des vaccins ?
(Interstices, 2020-07-08)Article de revue -
High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
(Science Advances. vol. 8, n° 45, 2022-11-11)Article de revue -
Using Population Based Kalman Estimator to Model COVID-19 Epidemic in France: Estimating the Effects of Non-Pharmaceutical Interventions on the Dynamics of Epidemic
(International Journal of Biostatistics, 2023-01-06)Article de revue -
Prospective evaluation of the first option, second-line Therapy in childhood chronic immune thrombocytopenia: splenectomy or immunomodulation
(Journal of Pediatrics. vol. 231, pp. 223-230, 2021-04)Article de revue -
Between-group comparison of area under the curve in clinical trials with censored follow-up: Application to HIV therapeutic vaccines
(Statistical Methods in Medical Research. vol. 30, n° 9, 2021-07-04)Article de revue -
Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multicentre study, DYNAPYO study
(The Journal of hospital infection. vol. 104, n° 1, pp. 40-45, 2020)Article de revue -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
(The Lancet Infectious Diseases, 2020-11-17)Article de revue -
Visualizing omics and clinical data: Which challenges for dealing with their variety?
(Methods. vol. 132, pp. 3-18, 2018-01-01)Article de revue -
A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1-and HIV-2-Infected Nonprogressors
(AIDS Research and Human Retroviruses, 2020-11-12)Article de revue -
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
(Journal of Immunology. vol. 208, n° 12, pp. 2663-2674, 2022-06-15)Article de revue